Around Right to Nonviolence
Regional Updates- Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia - The Manila Times 20/10/2026
- Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy - The Manila Times 19/10/2026
- Landmark China trial achieves 84% efficacy treating cancer with waste water tech - South China Morning Post 17/10/2026
- Saudi Justice Minister Welcomes Approval of New Enforcement Law, Thanks Leadership - وزارة العدل السعودية 12/10/2026
- Tortugas’ schizophrenia drug proves worth in phase 2 Hansoh trial in China - Fierce Biotech 12/10/2026
Email: info@righttononviolence.org - Tel: +961 1 612683
Except unless otherwise noted, content on this site is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License @ 2014 Right to Nonviolence. Some rights reserved.